Blog
12 December, 2018
Source: immedicohospitalario.es Systemic lupus erythematosus (SLE) is an autoimmune disease with multifaceted and extremely variable clinical manifestations, characterized by relapses and outbreaks followed by periods of […]
4 December, 2018
Source: Laverdad.es Spain has become the second country in the world where more clinical trials are carried out, only surpassed by the United States, the hegemonic […]
29 November, 2018
Source: redaccionmedica.com Different Spanish biotechnology companies and research groups presented on Wednesday a total of nine advanced innovative drug development projects to representatives of 17 national […]
22 November, 2018
Source: actasanitaria.com Researchers from the Health Research Institute of the Hospital Clínico de Valencia (INCLIVA) have shown that a molecule used to treat cancer, called PD033299, […]
20 November, 2018
Source: redaccionmedica.com The great results obtained with CAR-T therapies in cancer patients in whom chemotherapy has failed have focused the day ‘Towards a greater knowledge of […]
16 November, 2018
Source: redaccionmedica.com AstraZeneca has presented new analyzes of the Pegasus-Timi 54 trial in the framework of the Scientific Conferences of the American Heart Association. These findings […]
15 November, 2018
Source: actasanitaria.com A day after knowing the draft agreement on Brexit that last Tuesday, November 13, reached the European Union (EU) and the British Government, the […]
8 November, 2018
Source: actasanitaria.com The European Commission has approved a new indication of enzalutamide, a drug whose trade name is Xtandi and which was registered by the pharmaceutical […]
5 November, 2018
Source: actasanitaria.com In order to highlight the priorities of the sector when there are just over seven months left for the next European elections, a manifesto, […]
30 October, 2018
Source: actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has published the news regarding the submission of requests for regulatory activities of medicines for […]
25 October, 2018
Source: redaccionmedica.com The government has approved this Tuesday for 9.550.000 euros to attend the 2019 call for grants of the Strategic Plan for Research and Innovation […]
23 October, 2018
Source: immedicohospitalario.es Immunotherapy with pembrolizumab improves survival in patients with head and neck cancer that has recurred or metastasized according to the most recent results of […]
19 October, 2018
Source: redaccionmedica.com The biopharmaceutical company Gilead Sciences continues its commitment to research in our country, this time, developing a project to achieve the cure of HIV. […]
18 October, 2018
Source: redaccionmedica.com Currently, the pharmaceutical industry has a total of 169 new drugs against breast cancer in the clinical research phase, a disease that encompasses the […]
16 October, 2018
Source: redaccionmedica.com Actelion Pharmaceuticals has announced the results of the first randomized controlled trial in portopulmonary hypertension (HTPP). This study has shown that Opsumit (macitentan) significantly […]
10 October, 2018
Source: actasanitaria.com The European Commission has authorized the commercialization of Verzenios (abemaciclib), from the pharmaceutical company Lilly, as a treatment of locally advanced or metastatic breast […]
8 October, 2018
Source: immedicohospitalario.es New ways of researching and developing drugs, in their most advanced oncological aspects, urge health administrations, hospitals, patients and their organizations, Research Ethics Committees […]
5 October, 2018
Source: redaccionmedica.com Researchers at the Vall d’Hebron Institute of Oncology (VHIO) in Barcelona have achieved that immunotherapy attacks only the tumor cells of a type of […]
3 October, 2018
Source: IntraMed The American James Allison and the Japanese Tasuku Honjo have won the Nobel Prize for Medicine 2018. The jury of the Karolinska Institute in […]
26 September, 2018
Source: actasanitaria.com The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of the drug Gilenya (fingolimod), […]
21 September, 2018
Source: redaccionmedica.com The director of the Health Institute Carlos III (ISCIII), Raquel Yotti Álvarez, in charge of the head of the Spanish delegation at the opening […]
18 September, 2018
Source: Actasanitaria.com Within the framework of the 41st Annual Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM), which is being held in Santander, […]
13 September, 2018
Source: redaccionmedica.com The AstraZeneca Foundation, in collaboration with the Carlos III Health Institute, has announced the winners of the IV Young Researchers Awards, a recognition that […]
14 March, 2018
Distefar, considera que las funciones que se llevan a cabo en el servicio de farmacia hospitalaria, dentro del entorno de un estudio con medicamentos, son fundamentales […]
2 October, 2023
The 7th Congress of Patients’ Organisations, organised by the POP, analyses the application of the new European Regulation on Clinical Trials. Farmaindustria’s director general, Juan Yermo, […]
26 September, 2023
The vast majority of them are aimed at modifying the course of the disease, according to an Iqvia report on the future of R&D. In Spain […]
19 September, 2023
Only 7.5% are carried out in health centres. In order to alleviate this situation, Farmaindustria has presented a programme to promote them in outpatient clinics. Source: […]
14 September, 2023
“We are going to create a favourable environment”. This statement by José Manuel Miñones is the first step towards a roadmap that would highlight the key […]
12 September, 2023
“We must take advantage of the opportunity provided by the Spanish Presidency of the Council of the EU to include health, medicines and the innovative pharmaceutical […]
25 July, 2023
Over the next five years, the number of cancer treatments consisting of more than one drug will double, with 68 authorisations expected to be granted The […]
18 July, 2023
The forum, organised by the Menéndez Pelayo International University (UIMP) and Farmaindustria, will be held on 7 and 8 September in Santander Patient representatives, drug authorities, […]
10 July, 2023
The sector invests 41.5 billion euros in research and directly employs some 840,000 people 300 billion, exports ¤565 billion and contributes ¤175 billion to the EU-27 […]
4 July, 2023
Last year, the sector contributed 313 million euros for organisations and healthcare professionals to participate in research and development activities for new treatments For the eighth […]
27 June, 2023
One out of every three tests carried out in Europe takes place in Spain. Investment has grown by 5.3% annually since 2011, to almost 800 million […]
19 June, 2023
The associate director of Clinical and Translational Research at Farmaindustria, Amelia Martín Uranga, explained at a forum organised by the POP that work is already underway […]
30 May, 2023
On 23 May, part of the Distefar team attended the biomedical research technology platform. The opening was a conference by Juan José Vaquero, entitled “Strategy for […]
